142 related articles for article (PubMed ID: 1325431)
1. High sensitivity to peripheral blood lymphocytes and low HLA-class I antigen expression of small cell lung cancer cell lines with diverse chemo-radiosensitivity.
Tanio Y; Watanabe M; Osaki T; Tachibana I; Kawase I; Kuritani T; Saito S; Masuno T; Kodama N; Furuse K
Jpn J Cancer Res; 1992 Jul; 83(7):736-45. PubMed ID: 1325431
[TBL] [Abstract][Full Text] [Related]
2. Induction of intercellular adhesion molecule 1 on small cell lung carcinoma cell lines by gamma-interferon enhances spontaneous and bispecific anti-CD3 x antitumor antibody-directed lymphokine activated killer cell cytotoxicity.
Azuma A; Yagita H; Matsuda H; Okumura K; Niitani H
Cancer Res; 1992 Sep; 52(18):4890-4. PubMed ID: 1381273
[TBL] [Abstract][Full Text] [Related]
3. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
4. Immune response induced in small-cell lung cancer by maintenance therapy with interferon gamma.
Pujol JL; Gibney DJ; Su JQ; Maksymiuk AW; Jett JR
J Natl Cancer Inst; 1993 Nov; 85(22):1844-50. PubMed ID: 8230265
[TBL] [Abstract][Full Text] [Related]
5. ICAM-1 expression by lung cancer cell lines: effects of upregulation by cytokines on the interaction with LAK cells.
Melis M; Spatafora M; Melodia A; Pace E; Gjomarkaj M; Merendino AM; Bonsignore G
Eur Respir J; 1996 Sep; 9(9):1831-8. PubMed ID: 8880099
[TBL] [Abstract][Full Text] [Related]
6. IFN-gamma gene transfer restores HLA-class I expression and MAGE-3 antigen presentation to CTL in HLA-deficient small cell lung cancer.
Traversari C; Meazza R; Coppolecchia M; Basso S; Verrecchia A; van der Bruggen P; Ardizzoni A; Gaggero A; Ferrini S
Gene Ther; 1997 Oct; 4(10):1029-35. PubMed ID: 9415308
[TBL] [Abstract][Full Text] [Related]
7. Lysis of small cell carcinoma of the lung tumor cell lines by gamma interferon-activated allogeneic peripheral blood mononuclear cells: abrogation of killing by pretreatment of tumor cells with gamma interferon.
Ball ED; Nichols KE; Pettengill OS; Sorenson GD; Fanger MW
Cancer Immunol Immunother; 1986; 22(3):211-6. PubMed ID: 3015408
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression of HLA-A,B,C and inducibility of TAP-1, TAP-2, and HLA-A,B,C by interferon-gamma in a multidrug-resistant small cell lung cancer line.
Fisk B; Ioannides CG; Aggarwal S; Wharton JT; O'Brian CA; Restifo N; Glisson BS
Lymphokine Cytokine Res; 1994 Apr; 13(2):125-31. PubMed ID: 8061113
[TBL] [Abstract][Full Text] [Related]
9. The human lymphokine-activated killer cell system. V. Purified recombinant interleukin 2 activates cytotoxic lymphocytes which lyse both natural killer-resistant autologous and allogeneic tumors and trinitrophenyl-modified autologous peripheral blood lymphocytes.
Grimm EA; Wilson DJ
Cell Immunol; 1985 Sep; 94(2):568-78. PubMed ID: 3928175
[TBL] [Abstract][Full Text] [Related]
10. Expression of myeloid and major histocompatibility antigens on small cell carcinoma of the lung cell lines analyzed by cytofluorography: modulation by gamma-interferon.
Ball ED; Sorenson GD; Pettengill OS
Cancer Res; 1986 May; 46(5):2335-9. PubMed ID: 3008987
[TBL] [Abstract][Full Text] [Related]
11. Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells.
Mizutani Y; Bonavida B; Nio Y; Yoshida O
Cancer; 1993 Feb; 71(4):1313-21. PubMed ID: 7679609
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-2-inducible killer activity and its regulation by blood monocytes from autologous lymphocytes of lung cancer patients.
Sone S; Kunishige E; Fawzy F; Yanagawa H; Nii A; Maeda K; Atagi S; Heike Y; Nishioka Y; Mizuno K
Jpn J Cancer Res; 1991 Jun; 82(6):716-23. PubMed ID: 1649813
[TBL] [Abstract][Full Text] [Related]
14. Cytocidal activity of PBL, LAK, and IDEC-C2B8 and expression of HLA class 1, ICAM-1, and CD20 in vincristine-resistant hematologic cell lines.
Hirose M; Hamano S; Tobinai K; Kuroda Y
J Immunother; 1999 May; 22(3):237-44. PubMed ID: 10335483
[TBL] [Abstract][Full Text] [Related]
15. Lack of correlation between levels of MHC class I antigen and susceptibility to lysis of small cellular lung carcinoma (SCLC) by natural killer cells.
Stam NJ; Kast WM; Voordouw AC; Pastoors LB; van der Hoeven FA; Melief CJ; Ploegh HL
J Immunol; 1989 Jun; 142(11):4113-7. PubMed ID: 2541206
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of C-myc increases the sensitivity of Epstein-Barr virus immortalized lymphoblastoid cells to non-MHC-restricted cytotoxicity.
Cuomo L; Zhang QJ; Lombardi L; Torsteinsdottir S; Klein G; Dalla-Favera R; Masucci MG
Int J Cancer; 1993 Apr; 53(6):1008-12. PubMed ID: 8386135
[TBL] [Abstract][Full Text] [Related]
17. Interferon gamma enhances lymphokine-activated killer cell adhesion but not lysis of head and neck squamous cell carcinoma.
Scher RL; Carras A; Schwab D; Richtsmeier WJ; Koch WM
Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1271-5. PubMed ID: 7576474
[TBL] [Abstract][Full Text] [Related]
18. Bovine NK and LAK susceptibility is independent of class I expression on B lymphoblastoid variants.
Li W; Splitter GA
Vet Immunol Immunopathol; 1994 Jun; 41(3-4):189-200. PubMed ID: 7941303
[TBL] [Abstract][Full Text] [Related]
19. [The enhancement of cytolytic activity in lymphokine activated killer cells using bispecific F(ab')2].
Azuma A
Nihon Ika Daigaku Zasshi; 1991 Dec; 58(6):663-72. PubMed ID: 1663120
[TBL] [Abstract][Full Text] [Related]
20. Human small-cell lung-cancer cells are cytokine-resistant but NK/LAK-sensitive.
Lagadec PF; Saraya KA; Balkwill FR
Int J Cancer; 1991 May; 48(2):311-7. PubMed ID: 1850388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
